Veracyte agrees to acquire Convergent Genomics
Veracyte, Inc. has entered into a definitive agreement and plan of merger with Convergent Genomics, Inc. that will result in the latter becoming a wholly-owned subsidiary following the transaction.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day